Side-by-side comparison of AI visibility scores, market position, and capabilities
Berlin bootstrapped subscription management and billing platform at $2.9M revenue 2024 with 30 employees; Gartner Magic Quadrant Visionary 2024 for Recurring Billing competing with Zuora for user-centric B2B/B2C subscription commerce.
Keylight is a Berlin, Germany-based subscription management and recurring billing software platform — bootstrapped with $2.9 million in 2024 revenue (up from $2.1 million in 2023) and 30 employees — providing B2B and B2C subscription businesses in SaaS, e-commerce, financial services, energy and utilities, and manufacturing/IoT sectors with a unified platform for omnichannel commerce, subscription lifecycle management, CPQ (Configure, Price, Quote), billing automation, and revenue accounting. Named a Visionary in the 2024 Gartner Magic Quadrant for Recurring Billing Applications, Keylight differentiates from traditional finance-centric billing platforms through a user-centric architecture that prioritizes customer journey configurability and partner portal self-service alongside backend billing automation. Founded in 2015 by Daniel Werner (CEO) and Marco Sarich (Managing Director), operating across EMEA, North America, and APAC.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.